Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Volume 36 Issue 2, February 2018

Electron microscopy of T cells on a fluid lipid bilayer, supported by mesoporous silica micro-rods (pseudocolored). Cheung et al. show that this scaffold can be used to mimic antigen presentation to T cells, improving the outcome of T-cell expansion for adoptive cellular therapies (p 160). Image credit: Alexander Cheung, Sandeep Koshy and David Zhang.

Editorial

  • The UK government's strategic plan for the life sciences is short on ambition and capital.

    Editorial

    Advertisement

Top of page ⤴

News

Top of page ⤴

Data Page

Top of page ⤴

News Feature

  • A positive regulatory environment, combined with a raft of drug approvals that included the first US gene therapy, buoyed the sector in 2017. The FDA's flexibility and focus on marketplace competition is likely to galvanize innovators in the coming year. Chris Morrison reports.

    • Chris Morrison
    News Feature
Top of page ⤴

Correspondence

Top of page ⤴

Patents

Top of page ⤴

News & Views

Top of page ⤴

Brief Communication

Top of page ⤴

Article

Top of page ⤴

Letter

Top of page ⤴

Corrigendum

Top of page ⤴

Erratum

Top of page ⤴

Careers and Recruitment

Top of page ⤴

Search

Quick links